Design, simulate, refine: simulation-guided clinical trials for accelerated drug development.

Simulation-guided design enhances complex clinical trial planning by evaluating operating characteristics and refining protocols for accelerated drug development.

• Why it matters: Innovative trial strategies like adaptive designs and biomarker-guided enrollment increase complexity, making it challenging to ensure trial validity, safety, and efficiency without robust tools.
• What they did: The authors describe how simulation studies evaluate trial performance metrics such as error control, power, and adaptive decision probabilities, supporting design optimization and communication among stakeholders.
• The result: Implementing simulation-guided design can improve trial robustness, ethical standards, and operational practicality, ultimately facilitating the efficient delivery of safe and effective therapies to patients.